Chile vs Sweden: Cause of death, by non-communicable diseases, ages 0-4, female
Chile
48.9%
in 2021
Sweden
46.6%
in 2021
Chile rank
15th
Sweden rank
18th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Chile
- Sweden
How they compare
Chile currently reports 48.9% against 46.6% in Sweden, a difference of 2.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Sweden ahead.
Chile ranks 15th and Sweden ranks 18th of 185 countries.
Across the 3 decades both report, Chile averaged higher in 2 and Sweden in 1.
Head to head by decade
| Decade | Chile | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.1% | 55.6% | 12.6% | Sweden |
| 2010s | 47.5% | 46.3% | 1.2% | Chile |
| 2020s | 48.6% | 45.6% | 3.1% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Chile or Sweden?
- Chile, at 48.9% against 46.6% in Sweden as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Chile and Sweden?
- 2.3%, with Chile ahead.
- How many years of comparable data are there for Chile and Sweden?
- 6 years are reported by both, from 2000 to 2021.
- How do Chile and Sweden rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Chile ranks 15th and Sweden ranks 18th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.